These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
257 related items for PubMed ID: 16075409
1. Comparison of perfusion MRI by flow-sensitive alternating inversion recovery and dynamic susceptibility contrast in rats with permanent middle cerebral artery occlusion. Hofmeijer J, Schepers J, van der Worp HB, Kappelle LJ, Nicolay K. NMR Biomed; 2005 Oct; 18(6):390-4. PubMed ID: 16075409 [Abstract] [Full Text] [Related]
4. A flow sensitive alternating inversion recovery (FAIR)-MRI protocol to measure hemispheric cerebral blood flow in a mouse stroke model. Leithner C, Gertz K, Schröck H, Priller J, Prass K, Steinbrink J, Villringer A, Endres M, Lindauer U, Dirnagl U, Royl G. Exp Neurol; 2008 Mar; 210(1):118-27. PubMed ID: 18037417 [Abstract] [Full Text] [Related]
5. The time course of ischemic damage and cerebral perfusion in a rat model of space-occupying cerebral infarction. Hofmeijer J, Veldhuis WB, Schepers J, Nicolay K, Kappelle LJ, Bär PR, van der Worp HB. Brain Res; 2004 Jul 02; 1013(1):74-82. PubMed ID: 15196969 [Abstract] [Full Text] [Related]
6. Attempts to improve absolute quantification of cerebral blood flow in dynamic susceptibility contrast magnetic resonance imaging: a simplified T1-weighted steady-state cerebral blood volume approach. Wirestam R, Knutsson L, Risberg J, Börjesson S, Larsson EM, Gustafson L, Passant U, Ståhlberg F. Acta Radiol; 2007 Jun 02; 48(5):550-6. PubMed ID: 17520432 [Abstract] [Full Text] [Related]
7. Cerebral blood flow, blood volume, and mean transit time responses to propofol and indomethacin in peritumor and contralateral brain regions: perioperative perfusion-weighted magnetic resonance imaging in patients with brain tumors. Rasmussen M, Juul N, Christensen SM, Jónsdóttir KY, Gyldensted C, Vestergaard-Poulsen P, Cold GE, Østergaard L. Anesthesiology; 2010 Jan 02; 112(1):50-6. PubMed ID: 19952725 [Abstract] [Full Text] [Related]
8. Aspects on the accuracy of cerebral perfusion parameters obtained by dynamic susceptibility contrast MRI: a simulation study. Knutsson L, Ståhlberg F, Wirestam R. Magn Reson Imaging; 2004 Jul 02; 22(6):789-98. PubMed ID: 15234447 [Abstract] [Full Text] [Related]
13. Comparison of increased venous contrast in ischemic stroke using phase-sensitive MR imaging with perfusion changes on flow-sensitive alternating inversion recovery at 3 Tesla. Yamashita E, Kanasaki Y, Fujii S, Tanaka T, Hirata Y, Ogawa T. Acta Radiol; 2011 Oct 01; 52(8):905-10. PubMed ID: 21844118 [Abstract] [Full Text] [Related]
14. Comparison of FAIR perfusion kinetics with DSC-MRI and functional histology in a model of transient ischemia. Schepers J, Veldhuis WB, Pauw RJ, de Groot JW, van Osch MJ, Nicolay K, van der Sanden BP. Magn Reson Med; 2004 Feb 01; 51(2):312-20. PubMed ID: 14755657 [Abstract] [Full Text] [Related]
16. FAIR-TrueFISP imaging of cerebral perfusion in areas of high magnetic susceptibility differences at 1.5 and 3 Tesla. Boss A, Martirosian P, Klose U, Nägele T, Claussen CD, Schick F. J Magn Reson Imaging; 2007 May 01; 25(5):924-31. PubMed ID: 17410577 [Abstract] [Full Text] [Related]
17. Normobaric hyperoxia delays perfusion/diffusion mismatch evolution, reduces infarct volume, and differentially affects neuronal cell death pathways after suture middle cerebral artery occlusion in rats. Henninger N, Bouley J, Nelligan JM, Sicard KM, Fisher M. J Cereb Blood Flow Metab; 2007 Sep 01; 27(9):1632-42. PubMed ID: 17311078 [Abstract] [Full Text] [Related]
18. Absolute quantification of cerebral blood flow in normal volunteers: correlation between Xe-133 SPECT and dynamic susceptibility contrast MRI. Knutsson L, Börjesson S, Larsson EM, Risberg J, Gustafson L, Passant U, Ståhlberg F, Wirestam R. J Magn Reson Imaging; 2007 Oct 01; 26(4):913-20. PubMed ID: 17896379 [Abstract] [Full Text] [Related]
19. Tracer delay correction of cerebral blood flow with dynamic susceptibility contrast-enhanced MRI. Ibaraki M, Shimosegawa E, Toyoshima H, Takahashi K, Miura S, Kanno I. J Cereb Blood Flow Metab; 2005 Mar 01; 25(3):378-90. PubMed ID: 15674238 [Abstract] [Full Text] [Related]
20. Malignancy assessment of brain tumours with magnetic resonance spectroscopy and dynamic susceptibility contrast MRI. Fayed N, Dávila J, Medrano J, Olmos S. Eur J Radiol; 2008 Sep 01; 67(3):427-33. PubMed ID: 18442889 [Abstract] [Full Text] [Related] Page: [Next] [New Search]